Navidea Biopharma (NAVB) Reports Q1 Loss of $0.24

Navidea Biopharma (NYSE: NAVB) reported Q1 EPS of ($0.24), versus ($0.83) reported last year. Revenue for the quarter came in at $136 thousand, versus $275.65 thousand reported last year.

For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
• Anthropic delays planned IPO from October to November - WSJ